DOSTINEX

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug DOSTINEX contains one active pharmaceutical ingredient (API):

1	Cabergoline UNII LL60K9J05T - CABERGOLINE
	Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity.
	Read more about Cabergoline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOSTINEX Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G02CB03	Cabergoline	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8114C, 8115D
BR	Câmara de Regulação do Mercado de Medicamentos	522718030076017, 522718030076117
CA	Health Products and Food Branch	02242471
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00890376, 01662387, 01662393, 06896782, 06896807, 07314569, 07314575, 09278369, 09278375
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30180-04-12
EE	Ravimiamet	1121162, 1733509
ES	Centro de información online de medicamentos de la AEMPS	60867
FI	Lääkealan turvallisuus- ja kehittämiskeskus	117044
FR	Base de données publique des médicaments	69671845
GB	Medicines & Healthcare Products Regulatory Agency	138678, 161600, 20889, 376310
HK	Department of Health Drug Office	41290
HR	Agencija za lijekove i medicinske proizvode	HR-H-951850722
IE	Health Products Regulatory Authority	22406, 31854
IL	מִשְׂרַד הַבְּרִיאוּת	4064, 4363
IT	Agenzia del Farmaco	028988018, 028988032, 045770017
LT	Valstybinė vaistų kontrolės tarnyba	1008683, 1008684, 1008685
MT	Medicines Authority	MA505/01401
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	373M99
NG	Registered Drug Product Database	B4-5542
Switch country to Nigeria in order to find specific presentations of DOSTINEX
NL	Z-Index G-Standaard, PRK	37206
NZ	Medicines and Medical Devices Safety Authority	6883
PL	Rejestru Produktów Leczniczych	100094067, 100225061, 100260241, 100260590, 100264753, 100280321, 100341413, 100348190, 100358030, 100362792, 100365543, 100370930, 100385959, 100386769, 100390854, 100401747, 100412308, 100419486, 100423430, 100456136, 100464552, 100468535
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65037001, W65037002, W65037003, W65037004
SG	Health Sciences Authority	09545P
TN	Direction de la Pharmacie et du Médicament	3963051, 7963041
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308014436, 8681308014443
ZA	Health Products Regulatory Authority	28/21.12/0244